Clinical trial

A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients

NCT02235402

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-12-01

PhasePHASE4

Study timeline

Study start (unknown)1997-12-01Date precision: month

Registry last updated2014-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

LacidipineDRUG

BendrofluazideDRUG

PlaceboDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02235402 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.